Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.
Hansen N, Obel N, Christensen PB, Kjær M, Laursen AL, Krarup HB, Møller A, Schlichting P, Bukh J, Weis N; Danish Database for Hepatitis B and C (DANHEP)- group. Hansen N, et al. Among authors: schlichting p. BMC Infect Dis. 2011 Jun 21;11:177. doi: 10.1186/1471-2334-11-177. BMC Infect Dis. 2011. PMID: 21693019 Free PMC article.
Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C.
Christensen PB, Krarup HB, Laursen AL, Madsen PH, Pedersen C, Schlichting P, Orholm M, Ring-Larsen H, Bukh J, Krogsgaard K. Christensen PB, et al. Among authors: schlichting p. Scand J Gastroenterol. 2012 Sep;47(8-9):1115-9. doi: 10.3109/00365521.2012.694905. Epub 2012 Jun 7. Scand J Gastroenterol. 2012. PMID: 22670704
The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
Krogsgaard K, Bindslev N, Christensen E, Craxi A, Schlichting P, Schalm S, Carreno V, Trepo C, Gerken G, Thomas HC, et al. Krogsgaard K, et al. Among authors: schlichting p. J Hepatol. 1994 Oct;21(4):646-55. doi: 10.1016/s0168-8278(94)80114-2. J Hepatol. 1994. PMID: 7814812
Ascites fluid and plasma calprotectin concentrations in liver disease.
Homann C, Christensen E, Schlichting P, Philipsen EK, Graudal NA, Garred P. Homann C, et al. Among authors: schlichting p. Scand J Gastroenterol. 2003 Apr;38(4):415-20. doi: 10.1080/00365520310000870. Scand J Gastroenterol. 2003. PMID: 12739714
87 results